Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ardent Health, Inc.ARDT · Entity 4664 | SVP & Chief Accounting Officer | September 25, 2026 | September 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ardent Health, Inc.
Report date September 25, 2026 · Filed September 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 129,921 |
Reported balance
After 2026-09-25 transaction · row 1
1 source rowRow 1 · 2026-09-25 · Tax withholding · Disposed 524 · Balance 129,921 F1: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F2: Represents the closing price of the common stock of the Issuer on September 25, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
F2: Represents the closing price of the common stock of the Issuer on September 25, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 25, 2026 Filed Sep 29, 2026 16:52 UTC | Ardent Health, Inc. ARDT · Entity 4664 | Tax withholdingCommon Stock | 524 | $10.54 | $5,522.96 |
DisclosureSEC source: 0001628280-26-063790 · wk-form4_1790700719.xml · nonDerivative · entry 1 Byers David Raynor · CIK 0002030371 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,921 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F2 · price: Represents the closing price of the common stock of the Issuer on September 25, 2026. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 16:25 UTC | Ardent Health, Inc. ARDT · Entity 4664 | GrantCommon Stock | 11,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023206 · wk-form4_1775161541.xml · nonDerivative · entry 3 Byers David Raynor · CIK 0002030371 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,445 F4 · shares: Represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 16:25 UTC | Ardent Health, Inc. ARDT · Entity 4664 | Tax withholdingCommon Stock | 924 | $8.67 | $8,011.08 |
DisclosureSEC source: 0001628280-26-023206 · wk-form4_1775161541.xml · nonDerivative · entry 2 Byers David Raynor · CIK 0002030371 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,907 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F3 · price: Represents the closing price of the common stock of the Issuer on April 1, 2026. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 16:25 UTC | Ardent Health, Inc. ARDT · Entity 4664 | Tax withholdingCommon Stock | 819 | $8.56 | $7,010.64 |
DisclosureSEC source: 0001628280-26-023206 · wk-form4_1775161541.xml · nonDerivative · entry 1 Byers David Raynor · CIK 0002030371 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,831 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F2 · price: Represents the closing price of the common stock of the Issuer on March 31, 2026. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 16:17 UTC | Ardent Health, Inc. ARDT · Entity 4664 | GrantCommon Stock | 8,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-017711 · wk-form4_1773433019.xml · nonDerivative · entry 1 Byers David Raynor · CIK 0002030371 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,650 F1 · shares: Shares earned based on 2024 and 2025 performance under performance vesting restricted stock units awarded on July 18, 2024. Pursuant to the terms of the award, the shares will vest on December 31, 2026 contingent upon service through such date. Read SEC document |
| September 25, 2025 Filed Sep 30, 2025 07:48 UTC | Ardent Health, Inc. ARDT · Entity 4664 | Tax withholdingCommon Stock | 524 | $13.19 | $6,911.56 |
DisclosureSEC source: 0001628280-25-043159 · wk-form4_1759232933.xml · nonDerivative · entry 1 Byers David Raynor · CIK 0002030371 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,791 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F2 · price: Represents the closing price of the common stock of the Issuer on September 25, 2025. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 17:28 UTC | Ardent Health, Inc. ARDT · Entity 4664 | GrantCommon Stock | 11,565 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-016280 · wk-form4_1743629274.xml · nonDerivative · entry 2 Byers David Raynor · CIK 0002030371 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,315 F3 · shares: Represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2025, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 17:28 UTC | Ardent Health, Inc. ARDT · Entity 4664 | Tax withholdingCommon Stock | 676 | $13.75 | $9,295.00 |
DisclosureSEC source: 0001628280-25-016280 · wk-form4_1743629274.xml · nonDerivative · entry 1 Byers David Raynor · CIK 0002030371 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,750 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F2 · price: Represents the closing price of the common stock of the Issuer on March 31, 2025. Read SEC document |
| September 25, 2024 Filed Sep 27, 2024 16:46 UTC | Ardent Health, Inc. ARDT · Entity 4664 | GrantCommon Stock | 6,447 | $0.00 | $0.00 |
DisclosureSEC source: 0002030371-24-000004 · wk-form4_1727469957.xml · nonDerivative · entry 1 Byers David Raynor · CIK 0002030371 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,426 F1 · shares: Represents restricted stock units that vest in 3 substantially equal installments on each anniversary of September 25, 2024, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date. Read SEC document |
| July 18, 2024 Filed Jul 22, 2024 17:51 UTC | Ardent Health, Inc. ARDT · Entity 4664 | GrantCommon Stock | 8,329 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-001951 · form4.xml · nonDerivative · entry 1 Byers David Raynor · CIK 0002030371 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,979 F1 · shares: Represents restricted stock units that vest in 3 substantially equal installments on each anniversary of March 31, 2024, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.